Search This Blog

Tuesday, September 1, 2020

NOVARTIS AG Raised to Buy by Morgan Stanley

Morgan Stanley’s analyst Mark Purcell has upgraded his rating from Neutral to Buy. The target price has been lifted and is now set at CHF 101 compared to CHF 93 before.


Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)